Human fibrinogen – human alpha-thrombin complex (Fg-IIa complex)

The human fibrinogen – human alpha-thrombin complex is a pivotal molecular assembly in the coagulation cascade, where the serine protease thrombin (Factor IIa) converts soluble fibrinogen into insoluble fibrin (Mosesson, 2005, Journal of Thrombosis and Haemostasis). This enzymatic process involves thrombin binding to fibrinogen via its active site and exosite I, leading to the release of fibrinopeptides A and B (Bode, 2006, Blood Cells, Molecules, and Diseases). The formation of this complex is the final step of the common pathway in blood clotting, essential for maintaining vascular integrity after injury. Dysregulation or overactivity of this complex is a primary driver of pathological thrombosis, contributing to conditions such as deep vein thrombosis, pulmonary embolism, and myocardial infarction (Wolberg, 2007, Blood Reviews). Consequently, this complex is a major therapeutic target for anticoagulants, particularly direct thrombin inhibitors like bivalirudin and dabigatran (Di Nisio et al., 2005, New England Journal of Medicine). These drugs work by sterically hindering the interaction or blocking the catalytic site, thereby preventing the conversion of fibrinogen to fibrin (Lee & Ansell, 2011, Circulation). Clinical monitoring of this target's activity often utilizes biomarkers such as fibrinopeptide A or thrombin-antithrombin complexes. The primary safety concern associated with targeting this complex is the increased risk of major hemorrhage, as it impairs the body's natural hemostatic ability (Connolly et al., 2009, New England Journal of Medicine).

Other names

Thrombin-fibrinogen complexFibrinogen-thrombin complexFactor IIa-fibrinogen complexFibrinogen-alpha-thrombin complex

Direct thrombin inhibitors (DTIs) bind to the active site and/or exosite I of thrombin within the complex, preventing the enzyme from cleaving fibrinogen into fibrin monomers and thereby halting the final step of the coagulation cascade (Lee & Ansell, 2011, Circulation).